← FDA Drug Approvals (Drugs@FDA)
DOFETILIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS USA · Approved 2022-04-15
Drug application
- FDA Application #
ANDA210018- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- DOFETILIDE
- Generic name
- Dofetilide
- Active ingredients
- DOFETILIDE
- Dosage form
- CAPSULE
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- TEVA PHARMS USA
- First approval
- 2022-04-15
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown